D. E. Shaw & Co., L.P. 13D and 13G filings for Sarepta Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-25 8:14 pm Unchanged |
2025-07-18 | 13G | Sarepta Therapeutics, Inc. SRPT |
D. E. Shaw & Co., L.P. | 5,059,912 5.100% |
0 (Unchanged) |
Filing |
| 2025-07-25 4:08 pm Purchase |
2025-07-18 | 13G | Sarepta Therapeutics, Inc. SRPT |
D. E. Shaw & Co., L.P. | 5,059,912 5.100% |
5,059,912 (New Position) |
Filing |